Financials

v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash $ 7,729 $ 9,860
Restricted cash 75 75
Tax credit receivable 513 1,215
Prepaid expenses and other current assets 465 430
Total current assets 8,782 11,580
Property and equipment, net 106 153
Deposits 90 29
Operating lease right-of-use assets, net (including $115 and $152 respectively, to related party) 1,468 1,694
Total assets 10,446 13,456
Current liabilities:    
Accounts payable and accrued expenses 1,194 2,127
Current maturities of operating lease liabilities (including $54 and $49 respectively, to related party) 326 301
Total current liabilities 1,520 2,428
Long-term liabilities:    
Operating lease liabilities (including $63 and $104 respectively, to related party) 1,257 1,505
Total liabilities 2,777 3,933
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Common stock, $0.001 par value 100,000 shares authorized as of September 30, 2025 and December 31, 2024; 13,041 and 10,174 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively 13 10
Additional paid-in capital 347,479 342,931
Accumulated deficit (339,823) (333,418)
Total stockholders’ equity 7,669 9,523
Total liabilities and stockholders’ equity $ 10,446 $ 13,456

Source

v3.25.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Operating expenses:        
Research and development $ 954 $ 3,242 $ 3,436 $ 10,500
General and administrative 1,135 1,800 3,102 4,148
Total operating expenses 2,089 5,042 6,538 14,648
Loss from operations (2,089) (5,042) (6,538) (14,648)
Other income (expense):        
Interest income 22 111 87 482
Foreign exchange gain (loss) 18 (8) 46 (72)
Total other income, net 40 103 133 410
Net loss $ (2,049) $ (4,939) $ (6,405) $ (14,238)
Net loss per common share, basic $ (0.19) $ (0.49) $ (0.61) $ (1.40)
Net loss per common share, diluted $ (0.19) $ (0.49) $ (0.61) $ (1.40)
Weighted average number of common shares, basic 10,991 10,174 10,449 10,174
Weighted average number of common shares, diluted 10,991 10,174 10,449 10,174

Source

v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating activities:    
Net loss $ (6,405) $ (14,238)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 59 98
Right of use assets 226 247
Stock-based compensation 214 558
Operating lease liabilities (223) (142)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (96) 1,281
Tax credit receivable 702 238
Accounts payable and accrued expenses (933) (1,367)
Net cash used in operating activities (6,456) (13,325)
Investing activities:    
Purchases of property and equipment (12) (8)
Net cash used in investing activities (12) (8)
Financing activities:    
Proceeds from ATM sale of common stock, net of transaction costs 154
Proceeds from registered direct sale of common stock, net of transaction cost 4,183
Net cash provided by financing activities 4,337
Net decrease in cash and restricted cash (2,131) (13,333)
Cash and restricted cash at beginning of period 9,935 26,428
Cash and restricted cash at end of period 7,804 13,095
Non-cash investing and financing activities    
Initial recognition of right-of-use assets and lease liabilities $ 163

Source